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Purpose
N-of-1 trials have been used in medicine to generate
treatment information when evidence from randomized
controlled trials (RCTs) is not available or applicable. N-
of-1 study design maintains the methodological safe-
guards provided by RCTs (blinding, randomization and
controls) yet avoids the disadvantages associated with
large trials. A standardized method of reporting of N-of-
1 trials, such as the Consolidated Standards of Reporting
Trials (CONSORT), would greatly improve the quality
and consistency of trial reports in this area. The objec-
tive of this study was to develop a CONSORT Extension
for N-of-1 Trials (CENT).
Methods
Checklist items for the CENT guidelines were derived
from three systematic reviews on N-of-1 conduct, analy-
sis and meta-analysis. A structured process of obtaining
information from a group of experts to refine and fina-
lize the CENT guidelines was carried out. Two stages of
questionnaires asked participants to rate the relative
importance of suggested checklist items; the second
questionnaire was refined based on feedback from the
previous one. Participants included those known to have
interests in either RCT reporting or N-of-1 methodol-
ogy. Items included after the Delphi process were
debated and finalized during an in-person meeting.
Results
There were 44 unique respondents between the two
rounds of questionnaires. Based on questionnaire
results, topics chosen for discussion at the in person
meeting included: terminology (what is “N-of-1”?), ran-
domization and blinding, research vs. clinical care, and
analysis and meta-analysis. The CENT checklist was
refined and adapted to the format of the most recent
CONSORT 2010 statement.
Conclusion
N-of-1 trials may promote an evidence-based approach to
therapy so that families, health care providers and policy-
makers can make informed choices, and are relevant to
both conventional and complementary and alternative
medicine. The CONSORT ‘extension’ will facilitate critical
appraisal and interpretation of N-of-1 trials by providing
authors with guidance on how to improve reporting.
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